Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-08-12 | PUMA BIOTECHNOLOGY, INC. | MILLER MICHAEL PA...
(Director) |
S | Common Stock | D | 23358 | $3.49 - $3.49 | $81,465 |
| 2024-07-17 | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F
(Chief Financial Officer) |
S | Common Stock | D | 4156 | $3.70 - $3.70 | $15,381 |
| 2024-07-17 | PUMA BIOTECHNOLOGY, INC. | Ludwig Jeffrey Je...
(Chief Commercial Officer) |
S | Common Stock | D | 2598 | $3.70 - $3.70 | $9,615 |
| 2024-07-17 | PUMA BIOTECHNOLOGY, INC. | HUNT DOUGLAS M
(See Remarks) |
S | Common Stock | D | 3637 | $3.70 - $3.70 | $13,460 |
| 2024-07-17 | PUMA BIOTECHNOLOGY, INC. | AUERBACH ALAN H
(President and CEO) |
S | Common Stock | D | 21920 | $3.70 - $3.70 | $81,128 |
| 2024-07-02 | PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F
(Chief Financial Officer) |
S | Common Stock | D | 5295 | $3.27 - $3.27 | $17,306 |
| 2024-07-02 | PUMA BIOTECHNOLOGY, INC. | Ludwig Jeffrey Je...
(Chief Commercial Officer) |
S | Common Stock | D | 6051 | $3.27 - $3.27 | $19,777 |
| 2024-07-02 | PUMA BIOTECHNOLOGY, INC. | HUNT DOUGLAS M
(See Remarks) |
S | Common Stock | D | 4349 | $3.27 - $3.27 | $14,214 |
| 2024-07-02 | PUMA BIOTECHNOLOGY, INC. | AUERBACH ALAN H
(President and CEO) |
S | Common Stock | D | 18885 | $3.27 - $3.27 | $61,725 |
| 2024-06-18 | PUMA BIOTECHNOLOGY, INC. | WILSON TROY EDWARD
(Director) |
A | Common Stock | A | 27000 | $0.00 - $0.00 | $0 |
| 2024-06-18 | PUMA BIOTECHNOLOGY, INC. | Stuglik Brian M
(Director) |
A | Common Stock | A | 27000 | $0.00 - $0.00 | $0 |
| 2024-06-18 | PUMA BIOTECHNOLOGY, INC. | Senderowicz Adrian
(Director) |
A | Common Stock | A | 27000 | $0.00 - $0.00 | $0 |
| 2024-06-18 | PUMA BIOTECHNOLOGY, INC. | MILLER MICHAEL PA...
(Director) |
A | Common Stock | A | 27000 | $0.00 - $0.00 | $0 |
| 2024-06-18 | PUMA BIOTECHNOLOGY, INC. | MOYES JAY M
(Director) |
A | Common Stock | A | 27000 | $0.00 - $0.00 | $0 |
| 2024-06-18 | PUMA BIOTECHNOLOGY, INC. | Dorval Allison
(Director) |
A | Common Stock | A | 27000 | $0.00 - $0.00 | $0 |
| 2024-06-18 | PUMA BIOTECHNOLOGY, INC. | Cesano Alessandra
(Director) |
A | Common Stock | A | 27000 | $0.00 - $0.00 | $0 |
| 2024-06-13 | PUMA BIOTECHNOLOGY, INC. | WILSON TROY EDWARD
(Director) |
S | Common Stock | D | 27000 | $3.33 - $3.33 | $89,901 |
| 2024-06-13 | PUMA BIOTECHNOLOGY, INC. | Stuglik Brian M
(Director) |
S | Common Stock | D | 9900 | $3.39 - $3.39 | $33,528 |
| 2024-06-13 | PUMA BIOTECHNOLOGY, INC. | Senderowicz Adrian
(Director) |
S | Common Stock | D | 27000 | $3.33 - $3.33 | $89,818 |
| 2024-06-13 | PUMA BIOTECHNOLOGY, INC. | MOYES JAY M
(Director) |
S | Common Stock | D | 22000 | $3.34 - $3.34 | $73,466 |
| 2024-06-13 | PUMA BIOTECHNOLOGY, INC. | Dorval Allison
(Director) |
S | Common Stock | D | 11000 | $3.37 - $3.37 | $37,096 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |